Michael Michael (M Michael)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Neuroendocrine Tumors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

JMIR research protocols

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Senthil Lingaratnam, Mahek Shah, Joseph A Nicolazzo, Michael Michael, John Francis Seymour, Paul A James, Smaro Lazarakis, Sherene Loi, Carl M J Kirkpatrick
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer. Clinical and translational science 17 (5) (2024)
Senthil Lingaratnam, Mahek Shah, Joseph A Nicolazzo, Michael Michael, John Francis Seymour, Paul A James, Smaro Lazarakis, Sherene Loi, Carl M J Kirkpatrick
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer. Clinical and translational science 17 (5) (2024)
Senthil Lingaratnam, Mahek Shah, Joseph A Nicolazzo, Michael Michael, John Francis Seymour, Paul A James, Smaro Lazarakis, Sherene Loi, Carl M J Kirkpatrick
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer. Clinical and translational science 17 (5) (2024)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lisa Guccione, Karla Gough, Allison Drosdowsky, Timothy Jay Price, Nick Pavlakis, David K Wyld, David Ransom, Michael Michael, Penelope Schofield
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (10) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Michael Michael, Winston Liauw, Sue-Anne McLachlan, Emma Link, Annetta Matera, Michael Thompson, Michael Jefford, Rod J Hicks, Carleen Cullinane, Athena Hatzimihalis, Ian G Campbell, Simone Rowley, Phillip J Beale, Christos S Karapetis, Timothy Price, Mathew E Burge
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study. Cancer chemotherapy and pharmacology 88 (1) (2021)
Michael Michael, V Thursfield, L Te Marvelde, G Kong, R J Hicks
Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region. Asia-Pacific journal of clinical oncology (2021)
Zheng Liu, Jennifer H Martin, Winston Liauw, Sue-Anne McLachlan, Emma Link, Anetta Matera, Michael Thompson, Michael Jefford, Rod J Hicks, Carleen Cullinane, Athena Hatzimihalis, Ian Campbell, Simone Crowley, Phillip J Beale, Christos S Karapetis, Timothy Price, Mathew E Burge, Michael Michael
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites. European journal of clinical pharmacology (2021)
Vignesh Narasimhan, Josephine A Wright, Michael Churchill, Tongtong Wang, Rachele Rosati, Tamsin R M Lannagan, Laura Vrbanac, Anne B Richardson, Hiroki Kobayashi, Timothy Price, Gayle X Y Tye, Julie Marker, Peter J Hewett, Michael P Flood, Shalini Pereira, G Adam Whitney, Michael Michael, Jeanne Tie, Siddhartha Mukherjee, Carla Grandori, Alexander G Heriot, Daniel L Worthley, Robert George Ramsay, Susan L Woods
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Oliver Klein, Damien Kee, Ben Markman, Michael Michael, Craig Underhill, Matteo S Carlino, Louise Jackett, Caroline Lum, Clare L Scott, Adnan Nagrial, Andreas Behren, Jane Y So, Jodie Palmer, Jonathan S Cebon
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Lisa Guccione, Karla Gough, Allison Drosdowsky, Krista Fisher, Timothy Jay Price, Nick Pavlakis, Mustafa Khasraw, David K Wyld, David Ransom, Grace Kong, Megan Rogers, Simone Leyden, John Leyden, Michael Michael, Penelope Schofield
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention. JMIR research protocols 8 (12) (2019)
Erin Laing, Nicole K Kiss, Michael Michael, Karla Gough, Meinir Krishnasamy
Investigating Nutrition-Related Complications and Quality of Life in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Protocol for a Mixed-Methods Prospective Study. JMIR research protocols 7 (12) (2018)